Re: Rezum therapy for >/=80-mL benign prostatic enlargement: a large, multicentre cohort study. Elterman D, Chughtai B, Zorn KC, Bhojani N, et al. BJU Int 2022;130:697.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elterman D, Chughtai B, Zorn KC, Bhojani N, et al. Re: Rezum therapy for >/=80-mL benign prostatic enlargement: a large, multicentre cohort study. BJU Int 2022;130:697.
PMID: 36263585